ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Sevilla, AN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Cancer
Adenocarcinoma
Ovarian Cancer
Stomach Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Sevilla, AN, ESP:

CEB-01 in Locally Resectable Pancreatic Cancer

authorized chemotherapeutic agent. After surgical removal of the pancreatic cancer tumor, CEB 01 will be placed in the sur ...

Enrolling
Pancreatic Carcinoma
Drug: CEB-01
Procedure: Standard surgery

Phase 2

Cebiotex

Sevilla, Spain and 3 other locations

phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...

Enrolling
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Drug: AMG 193
Drug: Gemcitabine

Phase 1

Amgen
Amgen

Seville, Andalusia, Spain and 76 other locations

Phase 1b/2 study to assess the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic pancreatic du...

Active, not recruiting
Metastatic Pancreatic Ductal Adenocarcinoma
Biological: CD40 agonist mitazalimab in combination with chemotherapy

Phase 1, Phase 2

Alligator Bioscience

Seville, Spain and 13 other locations

or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Cancer Stage IV
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2, Phase 3

Panbela Therapeutics

Sevilla, Spain and 91 other locations

Conjugate M9140 in Participants with Advanced Non-Small Cell Lung Cancer (Substudy NSCLC);* PROCEADE PanTumor: A Phase 1b/2, Multicenter, O ...

Enrolling
Gastric Cancer
Non-Small Cell Lung Cancer (NSCLC)
Drug: M9140

Phase 1, Phase 2

Merck KGaA (EMD Serono)
Merck KGaA (EMD Serono)

Seville, Spain and 53 other locations

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....

Active, not recruiting
Breast Cancer
Biliary Cancer
Drug: Camizestrant
Drug: T- Dxd

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Seville, Spain and 67 other locations

efficacy of AZD9574 individually and in combination with anti-cancer agents in participants with advanced cancer that has recurred/...

Enrolling
Advanced Solid Malignancies
Drug: Datopotamab Deruxtecan (Dato-DXd)
Drug: AZD9574

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Seville, Spain and 32 other locations

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors th...

Active, not recruiting
Breast Cancer
Neuroendocrine Tumors
Drug: Entrectinib

Phase 2

Roche
Roche

Seville, Spain and 131 other locations

effective in participants with select advanced or metastatic solid tumors. The study is conducted in two parts - phase Ia (dose-escalation, ...

Enrolling
Esophageal Cancer
Advanced Solid Tumor
Drug: LY4101174

Phase 1

Lilly
Lilly

Seville, Spain and 27 other locations

and effective in participants with advanced, or metastatic solid tumors including urothelial cancer. The study is conducted in two ...

Enrolling
Esophageal Cancer
Advanced Solid Tumor
Drug: LY4052031

Phase 1

Lilly
Lilly

Seville, Spain and 28 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems